Par Drugs IPO vs Parshva Enterprises IPO

Comparison between Par Drugs IPO and Parshva Enterprises IPO.

IPO Details

Par Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Parshva Enterprises IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Par Drugs IPO is up to ₹8.10 Cr whereas the issue size of the Parshva Enterprises IPO is up to ₹3.46 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Parshva Enterprises IPO is ₹45.00 per share.

 Par Drugs IPOParshva Enterprises IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹51.00 per share₹45.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size2000 shares3000 shares
Fresh Issue Size15,88,000 shares7,68,000 shares
Fresh Issue Size (Amount)up to ₹8.10 Crup to ₹3.46 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total15,88,000 shares7,68,000 shares
Issue Size Total (Amount)up to ₹8.10 Crup to ₹3.46 Cr

IPO Timetable

Par Drugs IPO opens on May 03, 2019, while Parshva Enterprises IPO opens on Jun 19, 2019. The closing date of Par Drugs IPO and Parshva Enterprises IPO is May 08, 2019, and Jun 21, 2019, respectively.

 Par Drugs IPOParshva Enterprises IPO
Issue OpenMay 03, 2019Jun 19, 2019
Issue CloseMay 08, 2019Jun 21, 2019
Basis Of Allotment (Tentative)May 13, 2019Jun 27, 2019
Initiation of Refunds (Tentative)May 14, 2019Jun 28, 2019
Credit of Share (Tentative)May 15, 2019Jun 28, 2019
Listing date (Tentative)May 16, 2019Jul 01, 2019

Financials & KPIs

Par Drugs IPO P/E ratio is , as compared to Parshva Enterprises IPO P/E ratio of .

 Par Drugs IPOParshva Enterprises IPO
Financials

Company Financials (Restated Standalone)

Period Ended31 Mar 201931 Mar 201831 Mar 2017
Assets51.3653.9456.04
Total Income46.4142.4248.81
Profit After Tax2.421.501.85
EBITDA5.288.028.50
NET Worth29.1220.7019.20
Reserves and Surplus24.6412.2510.75
Total Borrowing11.5823.1324.81
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 201931 Mar 2018
Assets3.582.05
Total Income7.134.77
Profit After Tax0.300.04
EBITDA0.450.08
NET Worth3.202.01
Reserves and Surplus1.040.04
Total Borrowing0.230.00
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.55%100%
Promoter Shareholding (Post-Issue)72.5%73.09%
Market Cap₹31.38 Cr.₹13.55 Cr.

Shares Offered

In the Par Drugs IPO Retail Individual Investors (RII) are offered 7,80,000 shares while in Parshva Enterprises IPO retail investors are offered 7,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Par Drugs IPO and in Parshva Enterprises IPO.

 Par Drugs IPOParshva Enterprises IPO
Market Maker Reservation84,000 shares42,000 shares
NII7,78,000 shares3,84,000 shares
RII7,80,000 shares3,84,000 shares
Employee30,000 shares
Total15,88,000 shares7,68,000 shares

Bids Received (Subscription)

Par Drugs IPO subscribed 5.64x in total, whereas Parshva Enterprises IPO subscribed 1.20x.

 Par Drugs IPOParshva Enterprises IPO
NII (times)3.48x1.65x
RII (times)7.97x0.74x
Employee (times)1.00x
Total (times)5.64x1.20x

Compare with others

Compare:

Par Drugs IPO Vs Parshva Enterprises IPO